Technivie

Kathryn Dzintars, Pharm.D., BCPS
Technivie is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Technivie: combination pack of three medications, ombitasvir/paritaprevir/ritonavir. Indicated for the treatment of chronic hepatitis C virus (HCV) genotype 4 infection without cirrhosis with or without the addition of ribavirin.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 6, 2016

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Technivie ID - 540655 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2016/01/06/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540655/all/Technivie PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -